| 0 |
Glinide [EPC] |
3 |
0.0003 |
| 1 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
1 |
0.0003 |
| 2 |
Cephalosporin Antibacterial [EPC] |
1 |
0.0001 |
| 3 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
3 |
0.0001 |
| 4 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 5 |
Interleukin-17A Antagonist [EPC] |
1 |
0.0000 |
| 6 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 7 |
alpha-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 8 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 9 |
Osmotic Laxative [EPC] |
4 |
0.0000 |
| 10 |
Microtubule Inhibitor [EPC] |
2 |
0.0000 |
| 11 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 13 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 14 |
beta-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 15 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 16 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 19 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 20 |
Calcium [EPC] |
1 |
0.0000 |
| 21 |
Insulin Analog [EPC] |
3 |
0.0000 |
| 22 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 23 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 24 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 25 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 26 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 27 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 29 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |